Health Care Roundup: Market Talk

Dow Jones
03/19

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.

0225 GMT - Top Glove's near-term challenges appear largely priced in following share price declines since early January, Hong Leong Investment Bank analyst Chee Kok Siang says in a note. The glove maker is expected to post weaker results in fiscal 3Q than 2Q as unfavorable foreign-exchange movements and rising nitrile butadiene rubber prices are likely to weigh on margins, he says. Chee cuts his estimates of Top Glove's FY 2026-FY 2028 earnings by 1.1%-6.9% to factor in higher nitrile butadiene rubber costs and a stronger ringgit. Hong Leong cuts its target price on Top Glove to 0.54 ringgit from 0.60 ringgit, while maintaining a hold rating on the stock. Shares are 1.7% lower at 0.56 ringgit. (yingxian.wong@wsj.com)

0129 GMT - Top Glove is expected to see its core net profit weaken on-quarter in fiscal 3Q, as average selling price hikes only take effect in April while higher input costs are felt earlier, CIMB Securities analyst Chun Sung Oong says in a note. He notes that the glove maker has begun issuing price increase notices to offset rising synthetic rubber costs and a weaker ringgit, with planned hikes of $7-$9 per 1,000 pieces. Some customers may temporarily switch to cheaper natural latex gloves, he adds. CIMB cuts Top Glove's target price to 0.63 ringgit from 0.68 ringgit, while maintaining a hold rating on the stock, as its current valuation has largely priced in a potential earnings recovery. Shares are 0.9% lower at 0.57 ringgit. (yingxian.wong@wsj.com)

0128 GMT - Top Glove could benefit from short-term disruptions in synthetic rubber markets caused by the Middle East conflict, Maybank IB analyst Wong Wei Sum says in a note. That is because it can produce both nitrile and natural rubber gloves, offering alternatives for price-sensitive customers, she says. Management is confident of passing on higher nitrile latex costs thanks to inelastic demand and low inventory levels, she notes. Recent gains in nitrile latex prices and supply disruptions may trigger mixed responses among clients, including panic buying, temporary order delays and switches to natural rubber gloves, she says. However, overall demand is expected to remain resilient, supported by tight inventory levels across the supply chain, she adds. Maybank maintains a hold rating on Top Glove and keeps its target price at 0.62 ringgit. Shares are 1.7% lower at 0.56 ringgit. (yingxian.wong@wsj.com)

(END) Dow Jones Newswires

March 19, 2026 04:20 ET (08:20 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10